Sponsor

Soleno Therapeutics, Inc.

Clinical research sponsor

Published trials7

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

7 shown

Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeNCT07450664 · lead sponsor · 2025-11-26

ENROLLING_BY_INVITATION

Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeNCT05701774 · lead sponsor · 2023-01-31

ACTIVE_NOT_RECRUITING

An Open-Label Study of Diazoxide Choline in Patients With Genetic ObesitiesNCT05532020 · lead sponsor · 2023-01-01

UNKNOWN

An Open-Label Study of DCCR Tablet in Patients With PWSNCT04086810 · lead sponsor · 2019-10-01

WITHDRAWN

PWS Outcomes Assessment StudyNCT04102839 · lead sponsor · 2019-07-15

COMPLETED

Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal PeriodNCT03714373 · lead sponsor · 2018-10-01

COMPLETED

A Study of Diazoxide Choline in Patients With Prader-Willi SyndromeNCT03440814 · lead sponsor · 2018-05-09

COMPLETED

Sponsor roles

lead sponsor7

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.